MedTrace Logo

eTryton Left Main Registry Tryton Side Branch Stent® Tmt of Denovo CAD in LM and CFX Arteries

NCT02765646 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2019-04-26

No results posted yet for this study

Summary

The objective of this study is to demonstrate the clinical performance of the Tryton Side Branch Stent used in conjunction with a commercially available Drug Eluting Stent (DES) to treat de novo bifurcated lesions involving both the Left Main (LM) and Circumflex Coronary Artery(LCX).

Conditions

  • Left Main Coronary Artery Stenosis

Interventions

DEVICE

Coronary stent procedure (CSP)

Sponsors & Collaborators

  • Tryton Medical, Inc.

    lead INDUSTRY

Principal Investigators

  • Stylianos A Pyxaras, MD,FESC · Klinikum-Coburg, Germany

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-05-31
Primary Completion
2019-06-30
Completion
2019-08-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02765646 on ClinicalTrials.gov